CYTOTOXIC-CELLS IN IMMUNODEFICIENT ATHYMIC MICE

被引：75

作者：

BUDZYNSKI, W

RADZIKOWSKI, C

机构：

[1] Department of Tumor Immunology, Institute of Immunology and Experimental Therapy Polish Academy of Sciences, 53-114, Wroclaw, Czerska

来源：

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY | 1994年 / 16卷 / 03期

关键词：

D O I：

10.3109/08923979409007097

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：319 / 346

页数：28

共 88 条

[31]

HOLUB M, 1987, IMMUNE DEFICIENT ANI, P59

[32] SILICA ABROGATION OF MYCOBACTERIAL ADJUVANT CONTACT SUPPRESSION OF TUMOR-GROWTH IN RATS AND ATHYMIC MICE [J].

HOPPER, DG ;

PIMM, MV ;

BALDWIN, RW .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1976, 1 (03) :143-144

[33] A FUNCTIONAL AND PHENOTYPIC COMPARISON OF MURINE NATURAL-KILLER (NK) CELLS AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS [J].

HOSKIN, DW ;

STANKOVA, J ;

ANDERSON, SK ;

RODER, JC .

INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (05) :940-948

[34]

HOSKIN DW, 1989, CANCER IMMUNOL IMMUN, V29, P226

[35]

IKEHARA S, 1987, IMMUNE DEFICIENT ANI, P69

[36]

KALLAND T, 1987, J IMMUNOL, V138, P3640

[37]

KELLY SA, 1991, CANCER RES, V51, P4020

[38]

KENNEDY JD, 1992, J IMMUNOL, V148, P1620

[39]

KIKLY K, 1992, J IMMUNOL, V149, P403

[40] THE IMMUNOTHERAPY OF HUMAN CANCER WITH INTERLEUKIN-2 - PRESENT STATUS AND FUTURE-DIRECTIONS [J].

KOLITZ, JE ;

MERTELSMANN, R .

CANCER INVESTIGATION, 1991, 9 (05) :529-542

← 1 2 3 4 5 6 7 8 9 →